TCT-26 Long-Term Event Rates for Left Atrial Appendage Closure with WATCHMAN: PROTECT AF 5 Year and PREVAIL 3 Year Follow-up

Keyphrases

• Event Rate 100%
• Stroke Risk 100%
• Left Atrial Appendage 100%
• Watchman 100%
• Major Bleeding 66%
• Clinical Events 66%
• Risk Reduction 66%
• Randomized Clinical Trial 66%
• Non-valvular Atrial Fibrillation 66%
• Clinical Data 33%
• High Risk 33%
• Anticoagulation 33%
• Therapy Strategy 33%
• Low Dose Rate 33%
• Rate Ratio 33%
• Intent-to-treat 33%
• High-risk Population 33%
• Warfarin 33%
• Procedural Complications 33%
• Ischemic Stroke 33%
• Hemorrhagic Stroke 33%
• Modified Rankin Scale 33%
• Baseline Risk 33%
• Patients Included 33%
• Effusion 33%
• Boston Scientific 33%
• Patient-level Data 33%
• Long-course 33%
• Watchman Device 33%
• CHA2DS2-VASc Score 33%
• Stroke Outcome 33%
• Device Embolization 33%
• Appendage Closure 33%
• Atrial Appendage 33%

Medicine and Dentistry

• Apoplexy 100%
• Atrial Fibrillation 33%
• Risk Reduction 33%
• Major Bleeding 33%
• Anticoagulation 16%
• Brain Ischemia 16%
• Warfarin 16%
• High Risk Population 16%
• Intention-to-Treat Analysis 16%
• Cerebral Hemorrhage 16%
• Effusion 16%
• CHA2DS2-VASc Score 16%
• Device Embolization 16%
• Randomized Clinical Trials 16%